Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
aCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
bInstitute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou 310058, China
cHangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou 310058, China
dInnovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou 310018, China
eEngineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou 310000, China
fCenter for Medical Research and Innovation in Digestive System Tumors, Ministry of Education, Hangzhou 310020, China
gCancer Center, Zhejiang University, Hangzhou 310058, China
hZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Guangdong 528400, China
iCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China
* Corresponding authors.
收起